Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Buy from Canaccord Genuity

Tipranks - Tipranks - Sat Jan 31, 10:24AM CST

Canaccord Genuity analyst Shane Storey maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh today and set a price target of A$50.00.

Claim 50% Off TipRanks Premium

Storey covers the Healthcare sector, focusing on stocks such as Telix Pharmaceuticals, Actinogen Medical , and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh. According to TipRanks, Storey has an average return of 7.0% and a 50.99% success rate on recommended stocks.

Currently, the analyst consensus on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is a Strong Buy with an average price target of A$48.36.

See Insiders’ Hot Stocks on TipRanks >>

Based on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of A$1.34 billion and a net profit of A$348.54 million. In comparison, last year the company earned a revenue of A$1.22 billion and had a net profit of A$311.36 million

Read More on AU:RMD:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).